Welcome to LookChem.com Sign In|Join Free
  • or
isopropyl 4-[(3R,5aR,6R,7R,8aS)-7-hydroxy-6-[(E,3R)-3-hydroxy-4-phenoxy-but-1-enyl]-3,4,5,5a,6,7,8,8a-octahydro-2H-cyclopenta[b]oxepin-3-yl]butanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1262873-14-2

Post Buying Request

1262873-14-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1262873-14-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1262873-14-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,8,7 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1262873-14:
(9*1)+(8*2)+(7*6)+(6*2)+(5*8)+(4*7)+(3*3)+(2*1)+(1*4)=162
162 % 10 = 2
So 1262873-14-2 is a valid CAS Registry Number.

1262873-14-2Downstream Products

1262873-14-2Relevant academic research and scientific papers

Discovery of novel seven-membered prostacyclin analogues as potent and selective prostaglandin FP and EP3 Dual Agonists

Sugimoto, Isamu,Kambe, Tohru,Okino, Tomotaka,Obitsu, Tetsuo,Ohta, Nobukazu,Nishiyama, Taihei,Kinoshita, Akihiro,Fujimoto, Taku,Egashira, Hiromu,Yamane, Shinsaku,Shuto, Satoshi,Tani, Kousuke,Maruyama, Toru

, p. 107 - 112 (2017/12/12)

A novel series of prostaglandin analogues with a seven-membered ring scaffold was designed, synthesized, and evaluated for the functional activation of prostaglandin receptors to identify potent and subtype-selective FP and EP3 dual agonists. Starting fro

BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES

-

Paragraph 0317 - 0318; 0319; 0384; 0385, (2014/01/07)

Provided is a compound which has strong and sustaining intraocular pressure lowering action and, further, has no fear of side effect on eyes. Since a compound represented by the formula (I): wherein definition of each group is as described in the specific

BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES

-

Page/Page column 16; 19, (2012/05/21)

Since a compound represented by the general formula (I) (wherein definition of each group is as described in the specification), a salt thereof, a solvate thereof, or a prodrug thereof has strong and sustaining intraocular pressure lowering activity and,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1262873-14-2